Creative Planning
MNTA

Creative Planning’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Creative Planning’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,517
Closed -$26K – 4181
2017
Q2 		$26K Sell
1,517
-153
-9% -$2.33K ﹤0.01% 3010
2017
Q1 		$22K Buy
1,670
+53
+3% +$830 ﹤0.01% 3075
2016
Q4 		$24K Sell
1,617
-883
-35% -$11.7K ﹤0.01% 2972
2016
Q3 		$29K Buy
2,500
+900
+56% +$10.6K ﹤0.01% 2778
2016
Q2 		$17K Hold
1,600
– – ﹤0.01% 2924
2016
Q1 		$15K Sell
1,600
-32
-2% -$344 ﹤0.01% 2980
2015
Q4 		$24K Buy
1,632
+1,500
+1,136% +$25.1K ﹤0.01% 2722
2015
Q3 		$2K Buy
+132
New +$2.7K ﹤0.01% 4005
2015
Q2 		– Sell
-700
Closed -$11K – 3433
2015
Q1 		$11K Sell
700
-825
-54% -$10.7K ﹤0.01% 3159
2014
Q4 		$18K Sell
1,525
-425
-22% -$4.86K ﹤0.01% 2749
2014
Q3 		$22K Hold
1,950
– – ﹤0.01% 2496
2014
Q2 		$24K Hold
1,950
– – ﹤0.01% 2386
2014
Q1 		$23K Hold
1,950
– – ﹤0.01% 2290
2013
Q4 		$34K Hold
1,950
– – ﹤0.01% 1868
2013
Q3 		$28K Sell
1,950
-1,113
-36% -$17K ﹤0.01% 1902
2013
Q2 		$46K Buy
+3,063
New +$40.4K ﹤0.01% 1437

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Creative Planning's MNTA Position: Q3 2017 in Review

Creative Planning sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 1,517 shares — an estimated $26K sold.

Creative Planning first reported a position in MNTA in Q2 2013 and held it in 16 quarters. The position peaked at $46K in Q2 2013. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

  • Creative Planning reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 1,517 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $26K.
  • Creative Planning first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
  • Creative Planning's Momenta Pharmaceuticals, Inc. position peaked at $46K in Q2 2013.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.